Literature DB >> 6776915

Intravenous hyperalimentation. Effect on delayed cutaneous hypersensitivity in cancer patients.

J M Daly, S J Dudrick, E M Copeland.   

Abstract

Effects of nutritional repletion with intravenous hyperalimentation (IVH) on sequential skin test reactivity were evaluated in 160 malnourished cancer patients undergoing chemotherapy (76 patients), surgery (49 patients), radiation therapy (20 patients) and supportive care (15 patients). In the chemotherapy group, 45 patients had negative reactions initially, and 25 patients (55%) had at least one skin test convert to positive in an average period of 19 days of IVH. In the surgery group, 23 patients (46%) were initially positive and remained positive, 13 patients (24%) converted from negative to positive, and 13 patients (30%) remained negative or converted to negative. Postoperative complications occurred in 25% of positive reactors, compared with 69% (p < 0.01) of negative reactors. In the radiation therapy group, the skin tests of six patients (30%) remained positive, three patients (15%) converted from negative to positive and the skin tests of nine patients (45%) remained negative. In the supportive care group, the skin tests of 73% of the patients either remained positive or converted to positive with IVH within an average period of 11 days of treatment. Nutritional therapy with IVH was associated with restored skin test reactivity in 51% of malnourished cancer patients undergoing oncologic therapy. Radiation therapy was generally immunosuppressive despite adequate nutritional repletion. In surgical patients, positive skin test reactivity correlated directly with a favorable response to operative therapy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6776915      PMCID: PMC1344937          DOI: 10.1097/00000658-198011000-00001

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  19 in total

1.  Immunodepression after major surgery in normal patients.

Authors:  M S Slade; R L Simmons; E Yunis; L J Greenberg
Journal:  Surgery       Date:  1975-09       Impact factor: 3.982

2.  Effects of protein depletion and repletion on cell-mediated immunity in experimental animals.

Authors:  J M Daly; S J Dudrick; E M Copeland
Journal:  Ann Surg       Date:  1978-12       Impact factor: 12.969

3.  Effect of nonthymic irradiation on cellular immunocompetence.

Authors:  N A Silverman; J C Alexander; C Potvin; P B Chretien
Journal:  Surg Forum       Date:  1975

4.  Effects of intravenous nutrition on tumor growth and host immunocompetence in malnourished animals.

Authors:  J M Daly; E M Copeland; S J Dudrick
Journal:  Surgery       Date:  1978-11       Impact factor: 3.982

5.  Proceedings: Cellular immunity in cured cancer patients.

Authors:  P L Twomey; W J Catalona; P B Chretien
Journal:  Cancer       Date:  1974-02       Impact factor: 6.860

6.  Delayed hypersensitivity responses: the effect of surgery.

Authors:  J B Pietsch; J L Meakins; D Gotto; L D MacLean
Journal:  J Surg Res       Date:  1977-03       Impact factor: 2.192

7.  Effect of intravenous hyperalimentation on established delayed hypersensitivity in the cancer patient.

Authors:  E M Copeland; B V Fadyen; S J Dudrick
Journal:  Ann Surg       Date:  1976-07       Impact factor: 12.969

8.  Preoperative cell-mediated immune status of gastric cancer patients.

Authors:  K Orita; H Miwa; H Fukuda; M Yumura; Y Uchida
Journal:  Cancer       Date:  1976-12       Impact factor: 6.860

9.  The effects of nutrition and treatment of cancer on host immunocompetence.

Authors:  D M Ota; E M Copeland; J N Corriere; S J Dudrick
Journal:  Surg Gynecol Obstet       Date:  1979-01

10.  Prolonged depression of cellular immunity in cured laryngopharyngeal cancer patients treated with radiation therapy.

Authors:  J L Tarpley; C Potvin; P B Chretien
Journal:  Cancer       Date:  1975-03       Impact factor: 6.860

View more
  12 in total

Review 1.  Amino acid supplementation and exercise performance. Analysis of the proposed ergogenic value.

Authors:  R B Kreider; V Miriel; E Bertun
Journal:  Sports Med       Date:  1993-09       Impact factor: 11.136

2.  Parenteral nutrition in esophageal cancer patients.

Authors:  J M Daly; E Massar; G Giacco; O H Frazier; C F Mountain; S J Dudrick; E M Copeland
Journal:  Ann Surg       Date:  1982-08       Impact factor: 12.969

3.  Specific immune responses to skin test antigens following repeated multiple antigen skin tests in normal individuals.

Authors:  B Lesourd; W D Winters
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

4.  Anergy in high-risk surgical patients: the role of parenteral nutrition.

Authors:  D A Simonowitz; E P Dellinger; M R Oreskovich; J C Stothert; W A Edwards
Journal:  West J Med       Date:  1982-09

5.  Impact of cancer, type, site, stage and treatment on the nutritional status of patients.

Authors:  F Bozzetti; S Migliavacca; A Scotti; M G Bonalumi; D Scarpa; F Baticci; M Ammatuna; A Pupa; G Terno; C Sequeira; C Masserini; H Emanuelli
Journal:  Ann Surg       Date:  1982-08       Impact factor: 12.969

6.  Delayed hypersensitivity skin testing does not influence the management of surgical patients.

Authors:  R Brown; J Bancewicz; J Hamid; G Tillotson; C Ward; M Irving
Journal:  Ann Surg       Date:  1982-12       Impact factor: 12.969

7.  Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients.

Authors:  J M Daly; F N Weintraub; J Shou; E F Rosato; M Lucia
Journal:  Ann Surg       Date:  1995-04       Impact factor: 12.969

8.  Immune and metabolic effects of arginine in the surgical patient.

Authors:  J M Daly; J Reynolds; A Thom; L Kinsley; M Dietrick-Gallagher; J Shou; B Ruggieri
Journal:  Ann Surg       Date:  1988-10       Impact factor: 12.969

9.  Failure of delayed hypersensitivity skin testing to predict postoperative sepsis and mortality.

Authors:  R Brown; J Bancewicz; J Hamid; N J Patel; C A Ward; R J Farrand; R S Pumphrey; M Irving
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-20

10.  Serum albumin levels in cancer patients receiving total parenteral nutrition.

Authors:  R L McCauley; M F Brennan
Journal:  Ann Surg       Date:  1983-03       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.